Late Phase 2 Study of OPC-12759 Ophthalmic Suspension

Clinical trial NCT00475319 · COMPLETED

Trial details

NCT number: NCT00475319
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2007-05-01
Primary completion: 2008-03-01
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.